Cargando…
Unusual severe gastritis and gastric ulcers caused by pembrolizumab
Pembrolizumab (an immune checkpoint inhibitor)-related gastritis and gastric ulcers are rare immune-related adverse events, which are insufficiently treated with proton pump inhibitors (PPIs) therapy alone, and usually require systemic steroid therapy and even other biological agents (such as inflix...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860115/ https://www.ncbi.nlm.nih.gov/pubmed/34121670 http://dx.doi.org/10.4103/jpgm.JPGM_1132_20 |